A new way to monitor and adjust HIV treatment dosing at home
A platform for monitoring the efficacy and optimal dosing of long-acting ART
This study is all about helping people with HIV track how well their long-lasting medications are working from home, so they can get the right dose for their needs and feel their best.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10873846 on NIH RePORTER |
What this research studies
This research focuses on developing a platform that allows patients to monitor the effectiveness and optimal dosing of long-acting antiretroviral therapy (ART) for HIV treatment and prevention from the comfort of their homes. It aims to create at-home self-collection methods and point-of-care testing to measure drug concentrations, which can help tailor treatment plans to individual needs. By validating these methods, the research seeks to improve patient management and ensure that ART is used effectively in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are receiving long-acting ART or are at risk for HIV and considering pre-exposure prophylaxis (PrEP).
Not a fit: Patients who are not on long-acting ART or those who do not have access to the necessary testing methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective HIV treatment, reducing the risk of treatment failure and improving overall health outcomes for patients.
How similar studies have performed: Previous research has shown that monitoring drug concentrations can significantly impact treatment outcomes, suggesting that this approach has the potential for success.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Anderson, Peter L. — University of Colorado Denver
- Study coordinator: Anderson, Peter L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.